Výsledky vyhledávání - "Michelle Toth"

Akademický článek

Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol

Autor: Sarbattama Sen, Chloe Andrews, Michelle Toth-Castillo, Huseyin Aktas, Miguel-Angel Luque Fernandez, Steven Koon Wong, Jose Halperin

Publikováno v: BMJ Open, Vol 12, Iss 4 (2022)

Introduction The significant maternal and neonatal outcomes of gestational diabetes mellitus (GDM) make it a major public health concern. Mothers with GDM are at greater risk of pregnancy complications and their offspring are at higher risk of diabet

Externí odkaz: https://doaj.org/article/587e3bf4e3f64edeb0a57bc82bc395a5

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland

Autor: Delia Bogdanet, Michelle Toth Castillo, Helen Doheny, Louise Dervan, Miguel Angel Luque-Fernandez, Jose A. Halperin, Paula M. O’Shea, Fidelma P. Dunne

Publikováno v: Acta diabetologica.

Aim Even though most pregnancies are uneventful, occasionally complications do occur. Gestational diabetes is linked to an increased risk of adverse pregnancy outcomes. Early identification of women at risk of experiencing adverse outcomes, ideally t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15985b56c686d5a4d9398879b730d660
https://pubmed.ncbi.nlm.nih.gov/36309618

Zobrazit plný text záznamu

The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland

Autor: Delia Bogdanet, Michelle Toth Castillo, Helen Doheny, Louise Dervan, Miguel-Angel Luque-Fernandez, Jose A. Halperin, Paula M. O’Shea, Fidelma P. Dunne

Publikováno v: Journal of Clinical Medicine; Volume 11; Issue 13; Pages: 3895

The aim of this study was to evaluate the ability of second trimester plasma glycated CD59 (pGCD59), a novel biomarker, to predict the results of the 2 h 75 g oral glucose tolerance test at 24-28 weeks of gestation, employing the 2013 World Health Or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e09848d435cbcf376c4906138c88d9

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland.

Autor: Bogdanet, Delia, Castillo, Michelle Toth, Doheny, Helen, Dervan, Louise, Luque-Fernandez, Miguel Angel, Halperin, Jose A., O'Shea, Paula M., Dunne, Fidelma P.

Publikováno v: Acta Diabetologica; Feb2023, Vol. 60 Issue 2, p211-223, 13p

Zobrazit plný text záznamu

The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland

Autor: Delia Bogdanet, Michelle Toth Castillo, Helen Doheny, Louise Dervan, Miguel Angel Luque-Fernandez, Jose Halperin, Paula M. O'Shea, Fidelma P. Dunne

Publikováno v: Diabetes Research and Clinical Practice. 190:110023

AIMS: To evaluate the ability of first trimester plasma glycated CD59 (pGCD59) to predict gestational diabetes mellitus (GDM) at 24-28 weeks of gestation. METHODS: Prospectively, in 378 pregnant women, GDM was diagnosed using the one step 2 h 75 g or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c63377e23b28663098cb2c2e0ae3018
https://doi.org/10.1016/j.diabres.2022.110023

Zobrazit plný text záznamu

162-LB: Plasma Glycated CD59 Predicts Postpartum Glucose Intolerance after Gestational Diabetes

Autor: Chantal Mathieu, Jose Halperin, Michelle Toth Castillo, Katrien Benhalima, Annouschka Laenen, Dongdong Ma

Publikováno v: Diabetes. 70

pGCD59 is an emerging biomarker for diabetes and GDM. In studies of women undergoing GDM screening either early in pregnancy (week Disclosure K. Benhalima: None. D. Ma: None. M. Toth castillo: None. A. Laenen: None. C. Mathieu: Advisory Panel; Self;

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d75455e2e2473c4c3d72f4d29048f8cf
https://doi.org/10.2337/db21-162-lb

Zobrazit plný text záznamu

Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol

Autor: Chloe Andrews, Michelle Toth-Castillo, Huseyin Aktas, Miguel-Angel Luque Fernandez, Steven Koon Wong, Sarbattama Sen, Jose Halperin

Publikováno v: BMJ Open. 12:e054773

IntroductionThe significant maternal and neonatal outcomes of gestational diabetes mellitus (GDM) make it a major public health concern. Mothers with GDM are at greater risk of pregnancy complications and their offspring are at higher risk of diabete

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4edd45c958472a15cf8e6aeb7b5260f
https://doi.org/10.1136/bmjopen-2021-054773

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání